Fierce Pharma

Tenpoint scores FDA nod for vision-correction eye drop Yuvezzi, plans Q2 launch with $235M in tow

Combining two eye drops that have been on the market for at least 30 years each has earned Tenpoint Therapeutics an FDA ...
BioPharma Dive

Tenpoint wins FDA nod for combination presbyopia eye drop

The biotech also raised $235 million in debt and equity funding to support marketing of the drop, which it claims to be an ...
MedPage Today on MSN

FDA OKs More Eye Drops That Can Replace Reading Glasses

Once-daily carbachol/brimonidine tartrate significantly improves aging-related vision loss ...
Healio

FDA approves Yuvezzi eye drop for presbyopia

The FDA approved Yuvezzi, an eye drop for the treatment of presbyopia, with broad U.S. availability expected in the second quarter, according to a press release from Tenpoint Therapeutics. Yuvezzi ...

Biotech with Seattle presence raises $235 million ahead of drug launch

Tenpoint Therapeutics' treatment targets presbyopia, which causes close-up vision loss in aging adults. The company, whose ...